MTX was demonstrated to form adducts with anisole and p-cresol scavengers, and the TMSOTf cleavage methodology was also found to be inadequate due to the large number of side products formed. We report here that using Fmoc/Dde strategy is an appropriate method to circumvent the cleavage with HF or TMSOTf. (3) During the coupling of MTX with oligopeptide, structural and stereo isomers are formed. We have described here the suitable conditions of HPLC separation of these products. )] based polymeric polypeptides are efficient against Leishmania donovani parasite infection, but the mechanism of the effect is not known yet. We prepared therefore the 5(6)-carboxyfluorescein (Cf) labeled oligopeptide [Cf-K(AaAa)] (a: D-alanine, A: L-alanine) and the corresponding MTX conjugates [Cf-K(MTX-AaAa)] as model compounds for structure-activity experiments. The conjugate aimed to be synthesized with solid phase methodology on MBHA resin with Boc strategy, using FmocLys(Boc)-OH. However, various side reactions were identified. Here we report three problems observed during the synthesis as well as solutions developed by us: (1) unexpected cyclopeptide-formation with the lactone-carboxylic group of the Cf was detected, when Cf was attached to the α-amino group of the Lys residue on solid phase. This was avoided by changing the order of Cf incorporation with using Fmoc/Dde strategy. Alternatively, we have built the peptide with Fmoc strategy on solid phase first and performed the labeling with Cf-OSu subsequently in solution. (2) During HF cleavage of the protected conjugates, Handling Editor: J. Bode.
Introduction
Leishmaniasis is one of the most critical tropical diseases, as recognized by the World Health Organization (WHO Report 2000) . The treatment has not been fully resolved yet. chemotherapy is available; but the efficiency is threatened by the growing incidence of resistant parasites, together with the frequent and severe side effects (Sundar and Olliaro 2007; Das et al. 2013) .
A promising method for destroying the parasites in the cells could be the inhibition of the pterine or folate metabolism that is different from human metabolism via selective inhibition of the pteridine reductase, thymidylate synthase or dihydrofolate reductase enzymes (Schüttlekopf et al. 2005) . Methotrexate (MTX, )methylmethylamino]benzoyl]amino]pentanedioic acid, Fig. 1 ) could be considered as one of the specific inhibitors of dihydrofolate reductase enzyme. It was proven that MTX conjugated to bovine serum albumin or maleyl-BSA was internalized by macrophages and killed effectively the intracellular parasites (Mukhopadhyay and Basu 1990) .
Conjugates prepared in our laboratory with efficient antiparasitic effect containing carrier molecules are based on poly[Lys(DL-Ala m )], (signed as AK 1 ) polymeric polypeptide (Kóczán et al. 2002) . It contains a poly [L-Lys] backbone (the average degree of polymerization = 60-200) and an oligo[DL-Ala] side chain (on average 3-4 Ala/Lys) per monomeric unit. More, effective derivatives of this family of polypeptides with different amino acids in the side chain exhibiting different chemical properties (poly[Lys(X i -DL-Ala m )], XAK (see Footnote 1) or poly[Lys(DL-Ala m -X i )], AXK (see Footnote 1)) were described (Hudecz et al. 1993; Clegg et al. 1990) .
Our aim was to synthesize the appropriate compounds corresponding to the monomeric unit of AK and its 1 Nomenclature of branched chain polypeptides was used in accordance with the recommended nomenclature of graft polymers. Short codes of the polypeptides are based on one letter abbreviation of amino acids. X is a required amino acid in the side chain; m represents the average number of amino acids in the side chain; i represents average degree of substitution of amino acid X (i≤1) (IUPAC-IUB 1984) .
Cf-labeled MTX conjugates. Namely, Cf-K(AaAa)-NH 2 and Cf-K(MTX-AaAa)-NH 2 peptide were aimed to prepare for structure-activity studies (e.g., chemical stability, enzymatic degradation, antiparasitic activity).
Here we report on three pitfalls identified during the synthesis of the model peptides and conjugates, as well as solutions developed by us.
Methods

General
The structures of the peptides were verified with electrospray ionization mass spectrometry (ESI-MS) and UV spectrophotometry. The peptides were purified by reversedphase high-performance liquid chromatography (RP-HPLC) (97 %<). ESI-MS spectra were recorded on Bruker Daltonics Esquire 3000+ ion trap mass spectrometer. The reactions were monitored by RP-HPLC (Phenomenex Synergi C12, 4 µm, 120 Å, 4,6 × 300 mm column using eluent A: 0.1 % TFA/H 2 O, and eluent B: 0.1 % TFA/80 % acetonitrile-H 2 O (V/V), and gradient elution 20-80 % B (5-20 min) and UV detection: λ = 220 nm). The conjugates were purified by RP-HPLC on Phenomenex Jupiter C18, 5 µm, 10 × 300 mm column. Gradient elution 5-100 % B (5-60 min) for the crude product and 10-100 % B (5-55 min) for the isolated isomer and UV detection (λ = 220 nm) were applied.
Results and discussion
The Cf-K(MTX-AaAa)-NH 2 oligopeptide conjugate as a model compound (Fig. 2 ) was synthesized on solid phase with conventional peptide synthesis strategy. First, we have chosen Boc/MBHA strategy, using Fmoc-Lys(Boc)-OH as the first coupled amino acid. The side chain of the conjugate was built on the ε-amino group of the protected lysine residue with Boc-Ala followed by unprotected MTX. For coupling DIC/HOBt assisted activation was used. For the removal of the Boc group 33 % TFA/DCM (V/V), while Fig. 2 The schematic structure of Cf-AK-MTX polymer polypeptide conjugate (a) and of the peptide conjugate (b) corresponding to a monomeric unit for the deprotection of the N α -Lys 30 % piperidine/70 % DMF (V/V) was utilized. First, the Fmoc-Lys(Boc)-OH was coupled to the resin, then the Fmoc group was cleaved and Cf was attached to the N α -amino group of the lysine. It was followed by incorporating the alanine side residues also protected by Boc group and then the MTX. Finally, the conjugate was cleaved from the resin with HF using scavengers (0,5 g p-cresol or anisole/10 ml HF).
During the synthesis, we observed serious side reactions, outlined below together with the interpretation and the solution.
Acylation with the carboxyl group of Cf
Unexpected deletion sequences were observed during the attachment of Boc-protected alanine residues if Cf was present at the α-amino group of the resin attached lysine as demonstrated by MS spectra derived from the crude product (Fig. 4) .
The likely explanation of the presence of deletion sequences could be the tautomeric carboxylic form of the fluorescein moiety (Fig. 3 ) and its reaction with free amino group, which resulted in the formation of cyclopeptide intermediates.
These cyclic derivatives prevent the incorporation of the incoming amino acid and hydrolysed during the HF cleavage, thus short peptides with deletion sequences are present in the final products (Fig. 4) . In the state of the art conjugation practice the lactonebound carboxylic group of Cf is expected to be inactive towards amide bond formation. By the synthesis of this peptide, we demonstrate that under some conditions the reactivity of this carboxylic group cannot be neglected. We propose two strategies to avoid the formation of these cyclopeptides. First, by changing the order of Cf incorporation. Instead of the attachment Cf to the Lys(Boc)-Resin, its coupling could be performed as the last step of the synthesis after the removal of the Fmoc protection of the assembled peptide conjugate (Fmoc-K(MTX-AaAa)-Resin). For this, we have successfully used the Fmoc/Dde strategy (Scheme 1). Another alternative solution is the solution phase labeling of the free K(MTX-AaAa)-NH 2 peptide using Cf-OSu reagent (Scheme 2). Using either method we completed the synthesis of the aimed product with >97 % purity ( Fig. 5 ) with acceptable yields (>28 %).
Failure of Boc strategy for the synthesis
For labeling the conjugate with Cf-OSu in solution (Scheme 2), first we synthesized the K(MTX-AaAa) peptide derivative on MBHA resin with Boc strategy. During cleavage from the resin with liquid HF we used different scavengers. We observed adduct formations with the scavenger p-cresol as well as with anisole as evidenced by ESI-MS spectrum (Fig. 6) .
Therefore it was concluded that Boc strategy with HF cleavage seems to be inadequate for the synthesis of MTXcontaining peptide conjugates, because the sensibility of the MTX aromatic moiety on carbocation attack.
Based on the ESI-MS spectrum of the isolated product we have postulated the structure one of the possible adducts (Fig. 7) . Further studies are needed to clarify the exact position of substitution.
To avoid adduct formation we have tried TMSOTf based cleavage without success. We observed the formation of a complex mixture with more than ten components and the target compound was not identifiable with RP-HPLC analysis (data not shown).
To avoid the harsh cleavage conditions that are not compatible with MTX, we utilized Fmoc/Dde strategy on MBHA resin with Rink-amide spacer (Scheme 1). The mild cleavage circumstances (95 % TFA/2,5 % water/2,5 % TIS (V/V/V)) does not cause side reactions, thus the aimed peptide was possible to be synthesized with high purity (>97 %) and yield (>28 %).
Formation of MTX isomers
The RP-HPLC analysis of MTX-containing conjugates (MTX-AaAa, K(MTX-AaAa), Cf-K(MTX-AaAa)) showed three peaks of approximately equal intensity implying of isomer formation around the glutamic acid moiety of MTX.
The formation of such MTX isomers were studied earlier (Nagy et al. 1993) . The presence of α and γ MTX isomers in approximately equal quantities is not surprising, thus α and γ carboxylic groups of MTX have about the same reactivity under the used DIC/HOBt acylation system (Fig. 8) . Furthermore, the lack of a urethane type protecting group at α amino group of the MTX could result in racemisation around the alpha carbon, when coupling is done on the α carboxyl.
We observed that changing the coupling conditions does not alter the isomeric composition significantly, thus the most practical way to obtain the isomerically pure MTXpeptide conjugate was to separate the isomers by HPLC. All three MTX-peptide isomers (α L/D and γ L) isolated after semi-preparative RP-HPLC separation (Fig. 9) were characterized by ESI-MS. Co-injection experiments together with molecular mass values support the presence of all isomers.
Discussion
In our study, we identified the following possible side reactions that may interfere with the successful synthesis of MTX-oligopeptide conjugates:
a) The generally inert lactone-bound carboxylic group of Cf is proved to be responsible for acylation side reactions in the presence of DIC/HOBt activation. To circumvent this problem the coupling of Cf should be the last step of conjugate synthesis. b) MTX is proved to be sensitive for HF/TMSOTf cleavage conditions, thus these conditions should be avoided. c) The formation of three MTX isomers in about equal amounts are demonstrated. The isomerically pure model peptides obtained by HPLC can be useful to clarify the significance of this side reaction in the pharmacological behavior of the product. The formation of such isomer conjugates are known from previous studies (Nagy et al. 1993) in the case of peptide hormones.
The results can be utilized predominantly to study comparatively the biological properties (e.g., the effect on cell proliferation, cytotoxicity) of the peptides and the peptide conjugates (Table 1) . We wish to understand the fate of the active MTX-branched polypeptide conjugates reported earlier (Kóczán et al. 2002) in the cell. Therefore, we aim to utilize the MTX-oligopeptide conjugates as monomeric unit and follow its uptake as well as intracellular traffic and degradation. These experiments will be accomplished by, e.g., fluorescent microscopy examinations, flow cytometry measurements and cell proliferation test. Furthermore, the observations described could help to improve the synthesis of MTX-polymeric polypeptide conjugates with fluorophore labels. 
